C. Gaujoux-Viala

8.8k total citations · 1 hit paper
87 papers, 2.7k citations indexed

About

C. Gaujoux-Viala is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, C. Gaujoux-Viala has authored 87 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Rheumatology, 23 papers in Hematology and 19 papers in Immunology. Recurrent topics in C. Gaujoux-Viala's work include Rheumatoid Arthritis Research and Therapies (59 papers), Autoimmune and Inflammatory Disorders Research (22 papers) and Systemic Lupus Erythematosus Research (19 papers). C. Gaujoux-Viala is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (59 papers), Autoimmune and Inflammatory Disorders Research (22 papers) and Systemic Lupus Erythematosus Research (19 papers). C. Gaujoux-Viala collaborates with scholars based in France, Netherlands and United States. C. Gaujoux-Viala's co-authors include Laure Gossec, Robert Landewé, Sofía Ramiro, Maya H Buch, J. Nam, Bruno Fautrel, Josef S Smolen, Kevin Winthrop, Désirée van der Heijde and Bernard Combe and has published in prestigious journals such as Annals of the New York Academy of Sciences, Annals of the Rheumatic Diseases and Osteoporosis International.

In The Last Decade

C. Gaujoux-Viala

78 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

2014 536 citations Sofía Ramiro, C. Gaujoux-Viala et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Gaujoux-Viala France	22	2.0k	748	624	408	292	87	2.7k
Matija Tomšič Slovenia	28	1.7k 0.9×	606 0.8×	627 1.0×	441 1.1×	270 0.9×	131	2.8k
Cédric Lukas France	27	2.7k 1.3×	877 1.2×	929 1.5×	233 0.6×	349 1.2×	112	3.3k
Carine Salliot France	21	1.5k 0.7×	639 0.9×	453 0.7×	325 0.8×	313 1.1×	63	2.5k
Arnaud Constantin France	30	1.9k 1.0×	605 0.8×	829 1.3×	329 0.8×	304 1.0×	120	3.1k
Philippe Gaudin France	32	2.3k 1.1×	829 1.1×	644 1.0×	283 0.7×	408 1.4×	148	3.4k
Saedís Saevarsdóttir Sweden	31	1.7k 0.8×	471 0.6×	855 1.4×	308 0.8×	306 1.0×	103	2.7k
J. Nam United Kingdom	21	2.4k 1.2×	887 1.2×	723 1.2×	414 1.0×	262 0.9×	57	3.0k
Joseph Wajdula United States	21	2.7k 1.3×	1.2k 1.6×	1.1k 1.8×	479 1.2×	375 1.3×	35	3.4k
D. van der Heijde Netherlands	21	2.4k 1.2×	951 1.3×	955 1.5×	253 0.6×	215 0.7×	58	2.9k
Patrick Verschueren Belgium	25	1.7k 0.8×	480 0.6×	434 0.7×	259 0.6×	383 1.3×	178	2.5k

Countries citing papers authored by C. Gaujoux-Viala

Since Specialization

Citations

This map shows the geographic impact of C. Gaujoux-Viala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Gaujoux-Viala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Gaujoux-Viala more than expected).

Fields of papers citing papers by C. Gaujoux-Viala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Gaujoux-Viala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Gaujoux-Viala. The network helps show where C. Gaujoux-Viala may publish in the future.

Co-authorship network of co-authors of C. Gaujoux-Viala

This figure shows the co-authorship network connecting the top 25 collaborators of C. Gaujoux-Viala. A scholar is included among the top collaborators of C. Gaujoux-Viala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Gaujoux-Viala. C. Gaujoux-Viala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lukas, Cédric, C. Daïen, C. Gaujoux-Viala, et al.. (2025). Polypharmacy in Early Rheumatoid Arthritis: Impact on Treatment Response and Adverse Event Risk in a multicenter French prospective cohort study. ACR Open Rheumatology. 7(8). e70066–e70066. 1 indexed citations

Drouet, J., Clementina López‐Medina, Benjamin Granger, et al.. (2024). Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology International. 44(8). 1455–1468. 3 indexed citations

Sepriano, Alexandre, Sofía Ramiro, Désirée van der Heijde, et al.. (2024). Clinical and imaging outcomes of different phenotypes of axial spondyloarthritis: 5-year analysis of the DESIR cohort. Seminars in Arthritis and Rheumatism. 66. 152424–152424.

Ferreira, Ricardo J O, Bruno Fautrel, Alain Saraux, et al.. (2020). Patient Global Assessment of Disease Activity and Radiographic Progression in Early Arthritis: Three‐Year Results From the ESPOIR Cohort. Arthritis Care & Research. 73(9). 1300–1305. 9 indexed citations

Granger, Benjamin, Anna Moltó, C. Gaujoux-Viala, et al.. (2019). Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain. Arthritis Research & Therapy. 21(1). 63–63. 2 indexed citations

Bykerk, Vivian P., Andrew Blauvelt, Jeffrey R. Curtis, et al.. (2019). SAT0605 BODY MASS INDEX AND SYSTEMIC CORTICOSTEROID USE AS INDICATORS OF DISEASE BURDEN AND THEIR INFLUENCE ON THE SAFETY PROFILE OF CERTOLIZUMAB PEGOL ACROSS INDICATIONS. Annals of the Rheumatic Diseases. 78. 1396–1397. 1 indexed citations

Daïen, C., C. Hua, C. Gaujoux-Viala, et al.. (2018). Actualisation des Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde. Revue du Rhumatisme. 86(1). 8–24. 6 indexed citations

Gossec, Laure, John Kirwan, Maarten de Wit, et al.. (2018). Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients. Clinical Rheumatology. 37(6). 1503–1510. 12 indexed citations

Gaujoux-Viala, C., Nathalie Rincheval, Maxime Dougados, Bernard Combe, & Bruno Fautrel. (2017). Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort. Annals of the Rheumatic Diseases. 76(12). 2054–2060. 15 indexed citations

10.

Flipo, René‐Marc, et al.. (2016). OP0141 Which Strategies in Rheumatoid Arthritis Patient with Inadequate Response To Methotrexate Monotherapy: The Stratege Study. Annals of the Rheumatic Diseases. 75. 109–109. 1 indexed citations

11.

Gossec, Laure, et al.. (2015). Version patient des recommandations de prise en charge de la polyarthrite rhumatoïde : une collaboration entre la Société française de rhumatologie et des associations de patients atteints de polyarthrite rhumatoïde. Revue du Rhumatisme. 82(6). 373–377.

12.

Tsonaka, Roula, et al.. (2015). Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts. Annals of the Rheumatic Diseases. 74(5). 806–812. 138 indexed citations

13.

Gaujoux-Viala, C., Anne‐Christine Rat, Françis Guillemin, et al.. (2014). THU0432 Impact of Comorbidities on Measuring Indirect Utility by the SF-6D or the EQ-5D in Rheumatoid Arthritis: an Analysis of 962 Patients Enrolled in Comedra. Annals of the Rheumatic Diseases. 73. 332–332. 1 indexed citations

14.

Mitrovic, Stéphane, L. Fardet, Camille Vatier, et al.. (2014). THU0142 Safety of Glucocorticoids for Early Rheumatoid Arthritis: A Meta-Analysis of Randomised Controlled Trials. Annals of the Rheumatic Diseases. 73. 228–228. 1 indexed citations

15.

Ramiro, Sofía, C. Gaujoux-Viala, J. Nam, et al.. (2014). Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 73(3). 529–535. 536 indexed citations breakdown →

16.

Nam, J., Sofía Ramiro, C. Gaujoux-Viala, et al.. (2014). Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 73(3). 516–528. 266 indexed citations

17.

Gaujoux-Viala, C., et al.. (2012). Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort. Lara D. Veeken. 51(9). 1648–1654. 13 indexed citations

18.

Gaujoux-Viala, C., T. Gaujoux, Hang‐Korng Ea, et al.. (2011). Scleritis: A Paradoxical Effect of Etanercept? Etanercept-associated Inflammatory Eye Disease. The Journal of Rheumatology. 39(2). 233–239. 65 indexed citations

19.

Gaujoux-Viala, C., et al.. (2011). La comparaison de la sensibilité au changement de l’EQ-5D et du SF-6D chez les patients souffrant d’arthrite débutante est en faveur de l’utilisation du SF-6D : résultats de la cohorte française ESPOIR. Revue d Épidémiologie et de Santé Publique. 59. S26–S26. 1 indexed citations

20.

Généreau, T, Jean Donadieu, Jean‐François Emile, et al.. (2011). Langerhans’ cell histiocytosis of the liver in adults. Clinics and Research in Hepatology and Gastroenterology. 35(6-7). 475–481. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact